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ABSTRACT
Nineteen American infants aged less than three months developed persistent diarrhoea, acidosis, hypo-
albuminaemia, and malnutrition, without evidence of enteric pathogens. Symptoms began 11-59 days
before admission to the University of North Carolina Children's Hospital, and infants were fed semi-
elemental formula. Despite further treatment with amino acid-based formula by continuous nasogastric
infusion, diarrhoea persisted. Endoscopic biopsies showed inflammation in the stomach, duodenum,
and/or colon. A trial of intravenous corticosteroids was initiated in 14 infants. Corticosteroids were
associated with rapid resolution of diarrhoea (duration after corticosteroids=3.8±1.7 days [mean+SD]).
In contrast, five infants with identical history were not treated with corticosteroids. In three infants, diar-
rhoea lasted  for 92-147 days versus 31±3 total days in the treated group. In the other two infants, diar-
rhoea worsened after discharge, but were treated later with corticosteroids, with rapid resolution. Cortico-
steroids were uneventfully weaned over a four-month period. The results suggest that a trial of cortico-
steroids in infants with unresponsive persistent diarrhoea of unknown origin is beneficial and deserves
prospective evaluation.
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INTRODUCTION
We recently noted the appearance of a condition charac-
terized by chronic diarrhoea, weight loss, hypoalbumi-
naemia, and acidosis in infants aged less than three
months. These were all previously healthy infants with
normal feedings who developed acute diarrhoea that be-
came protracted. Many developed severe dehydration,
and nearly half of the infants were initially admitted to
the intensive care unit at their local hospital. We present
19 infants with protracted diarrhoea and suggest that
corticosteroids dramatically corrected the problem in 16
infants who received this treatment. 
MATERIALS AND METHODS
During 1 January 1999_31 July 2002, 19 infants aged
less than three months were admitted to the University 
of North Carolina Children's Hospital (UNC Hospital)
with chronic diarrhoea, weight loss, acidosis, and hypo-
albuminaemia. Charts were reviewed retrospectively.
Protracted diarrhoea was defined as diarrhoea that per-
sisted for longer than 14 days even after feeding with
semi-elemental and amino acid-based formula.
All infants had the following laboratory studies: se-
rum electrolytes, calcium, magnesium, phosphate, total
protein, albumin, liver enzymes, serum trypsinogen, IgG,
IgM, IgA, blood urea nitrogen, and creatinine. Each in-
fant had a sweat chloride test and complete blood count.
Eight infants had IgE RAST testing for cow-milk and
soy-proteins. Each infant had a barium contrast study
of the upper gastrointestinal tract to rule out malrotation,
partial obstruction, or stagnant loop.
Stools were examined for rotavirus using EIA (Pre-
mier Rotaclone, Meridian Bioscience Inc, Cincinnati,
OH), Clostridium difficile toxin, ova and parasites, cul-
ture and sensitivity, including Escherichia coli O157:H7,
white blood cells (WBCs), and haemoccult. Endoscopy
of the oesophagus, stomach, and duodenum (EGD) and
colonoscopy with biopsies were performed in 13 infants.
Twelve patients were tested for HIV.
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Patients were hospitalized at the UNC Hospital and put
on parenteral nutrition and/or continuous nasogastric
feeding with Neocate (SHS International, Gaithersburg,
MD), an amino acid-based formula. When a decision
was made to start corticosteroids, they were initially ad-
ministered intravenous solumedrol 2 mg/kg per day. As
infants responded, they were transitioned to oral predni-
sone 2 mg/kg per day and eventually slowly weaned over
2-4 months.
Weight gain was defined as gaining 20 g per day for
at least one week.  Resolution of diarrhoea was defined
as when stool frequency was less than four formed stools
per day, and there was no need for intravenous fluids.
RESULTS
Description of patients 
Of the 19 infants identified over a 3.5-year period, 15
were male, and 15 were African-American (12 were
African-American male) (Table 1). None was born pre-
maturely or with parental consanguinity. Initial feeding
included breastmilk in four and cow-milk-based formula
in 15 infants. All infants received amino acid-based
formula within 24 hours of admission to the UNC Hos-
pital but had not received it earlier. Fourteen infants
received treatment with corticosteroids ('corticosteroids'
group). Five infants did not receive corticosteroids ini-
tially because parents refused treatment ('no-cortico-
steroids' group). 
Diarrhoea began 7-73 days after birth and did not
respond to 1-20 day(s) of feeding with semi-elemental
formulae (SEF, Alimentum, Ross Laboratories, Colum-
bus, OH, and Pregestimil, Mead Johnson, Evansville,
IL) prior to admission to the UNC Hospital (Table 1).
All infants had significant weight loss, hypoalbuminae-
mia, and acidosis when first admitted to the institution
despite prior intravenous fluid treatment at referring hos-
pitals. Six infants were transferred directly to the pae-
diatric intensive care unit at the UNC Hospital, but for
other infants, transfer to the UNC Hospital was delayed
because they appeared vigorous, well-fed, and well-hy-
drated clinically.  
Parents of five infants declined corticosteroid treat-
ment, parenteral nutrition, and endoscopy. They left the
hospital without resolution of diarrhoea of their infants.
These infants appeared to be stable with respect to hy-
dration, and there was cessation of weight loss at the time
of discharge, but they had not gained weight at the UNC
Hospital. Two infants returned to the UNC Hospital 16
and 20 days after discharge with further weight loss and
severe acidosis. Their parents subsequently accepted
corticosteroid treatment, but they did not consent to en-
doscopy with biopsies. The other three infants were fol-
lowed every 2-4 weeks and slowly improved (Table 2).
The only initial difference between the no-corticosteroids
group and the corticosteroids group was that 13 of 14
infants in the corticosteroids group had either visible
blood with WBCs (n=9) or WBCs without gross blood
(n=5) in stool, but only one of five infants in the no-
corticosteroids group had blood or WBCs in stool.
On admission, both the groups had a history of signi-
ficant weight loss despite coming from referral hospitals
where they were treated with intravenous hydration and
semi-elemental formulae. Twelve of the 17 infants who
were admitted before 60 days of age weighed less than  their
Table 1. Features of patients with chronic diarrhoea
Clinical feature Corticosteroids group         No-corticosteroids group
Number of patients 14 5
Initial feeds BF (3), C (11) BF (1), C (4)
Antibiotic used before admission 3 1
Duration (days) of symptoms before admission 15.6±8.3 (3-34) 15.6±11.0 (5-32)
Duration (days) of SEF before admission 8.7±5.1 (1-20) 10.0±4.1 (4-14)
Age (days) on admission 50.0±20.4 (26-90) 39.6±12.3 (27-60)
Initial serum bicarbonate (mEq/dL) 12.1±1.8 (8-15) 9.8±2.9 (6-14)
Initial serum albumin (g/dL) 2.2±0.6 (1.0-3.1) 2.16±0.3 (1.7-2.2)
Initial haemoglobin (g/dL) 9.1±1.5 (6.7-10.6) 8.91±0.7 (8.0-9.5)
Haemoccult-positive stool 13/14 1/5
Weight less than birth-weight* 9/12 3/5
Weight loss before admission 7.3±4.9% (0-27) 5.2±3.6% (0-12)
Abnormal histology† 13/13 NA
*Admitted infants were aged less than 60 days, whose weights were below their birth-weights
†Inflammation in at least one site biopsied (stomach, duodenum, colon)
All values are mean±SD
BF=Breastfeeding; C=Cow-milk-based formula; NA=Not applicable; SEF=Semi-elemental formulae
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birth-weight. No patients had received parenteral nutri-
tion at the referral hospitals. However, seven of the cor-
ticosteroids group received parenteral nutrition at the
UNC Hospital. Since they were not improving on amino-
acid formula and parenteral nutrition, they underwent
endoscopic biopsies 15.2±7.9 days after admission to
the UNC Hospital, and corticosteroid treatment was star-
ted 16.6±8.8 days after admission.  
Laboratory findings 
Despite low levels of serum albumin (Table 1), no infants
were oedematous. Serum blood urea nitrogen ranged 
duration of symptoms before admission, duration of feed-
ing with semi-elemental formulae before admission, per-
centage of weight loss, serum bicarbonate on admission,
serum albumin, and haemoglobin concentration (Table 1).
Histological findings 
Endoscopic biopsies were performed of the stomach,
duodenum, and colon in 13 infants 2-38 days after ad-
mission to the UNC Hospital and prior to corticosteroid
therapy (Table 3). At least one site was histologically
abnormal in all infants biopsied, but the findings were
not pathognomonic of any specific process. The major 
Table 2. Recovery of patients with chronic diarrhoea
Response to treatment Corticosteroids    No-corticosteroids/          No-corticosteroids group                 relapse group
Number 14 2 3
Time (days) to start treatment with cor-     
ticosteroids after onset of symptoms* 17-59 (27±11) 39, 41 NA
Duration (days) of SEF plus AAF     
before treatment with corticosteroids 15-48 (20±9) 33, 36 NA
Time (days) for diarrhoea to cease    
after treatment with corticosteroids    
was started 2-8 (3.8±1.7) 3, 4 [Not treated. Diarrhoea persisted]
Time (days) to achieve weight gain    
after treatment with corticosteroids    
was started 3-15 (5.4±2.7) 4, 5 NA
Time (days) for albumin to reach    
above 3.5 g/dL after treatment    
with corticosteroids was started 3-30 (12.4±5.4) 8, 14 NA
Total time† of diarrhoea 18-63 (31±11) NA 88, 96, 132 (105±23)
Total time† for weight gain 20-67 (32±11) NA 89, 99, 136 (108±25)
Total time† to normalize albumin 20-71 (39±14) NA 92, 101, 141 (111±26)
*Values are given as a range in days, then in parentheses as mean±SD
†Time from onset of symptoms to resolution of diarrhoea, increased weight gain, or normalization of albumin
AAF=Amino-acid formula; NA=Not applicable; SD=Standard deviation; SEF=Semi-elemental formulae
from 5 to 24 mg/dL, and all patients had a normal serum
creatinine. Within 1-3 day(s) after admission to the UNC
Hospital, aggressive intravenous rehydration and initia-
tion of amino-acid-based formula by continuous nasogas-
tric feeding resulted in a normal serum bicarbonate in all
the infants. No patients had significant peripheral blood
eosinophilia. All stool cultures, including those for Sal-
monella, Yersinia enterocolitica, Shigella, Campylobac-
ter jejuni, and E. coli 0157:H7, rotavirus EIA, tests for
ova and parasites, and C. difficile toxin assays were ne-
gative at the UNC Hospital. All values of sweat chloride
test and all upper gastrointestinal contrast barium studies
were normal. All 12 patients tested for HIV were negative.
Similar features for the no-corticosteroids group and
the corticosteroids group included age on admission, 
finding was mild-to-moderate inflammation. In addition,
severe duodenal villus blunting was noted in four infants.
Five infants had inflammation in all three sites biopsied.
Only one patient had tissue eosinophilia which was
colonic.
The figure, a photomicrograph of a duodenal biopsy,
demonstrates villus blunting and monocytic cell infiltra-
tion in the lamina propria. There is crypt hyperplasia
and focal cryptitis.  
Response to treatment 
The corticosteroids group included a subset of seven in-
fants who received parenteral nutrition. The mean dura-
tion of admission for infants receiving parenteral nutri-
tion was 24.3±11.0 days. The duration of admission to 
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the UNC Hospital for seven other infants in the cortico-
steroids group who did not receive parenteral nutrition
was 13.1±4.0 days (p<0.001). The difference in duration
of admission occurred because the infants on parenteral
nutrition started corticosteroids after 16.6±8.8 days (10-
41 days) compared to those without parenteral nutrition
who started corticosteroids only 6.3±3.6 days (2-12 days)
after admission (p<0.005).  
The duration of admission to the UNC Hospital was
not significantly different for infants in the no-cortico-
steroids group (12.2±2.7 days) compared to infants treated
with corticosteroids who did not receive parenteral nutri-
tion (13.1±4.0 days). However, diarrhoea had not resolved
when the infants in the no-corticosteroids group were
discharged, but diarrhoea was totally resolved in the cor-
ticosteroids group when discharged.
Table 4 compares the recovery rates of the cortico-
steroids and no-corticosteroids groups. The patients in
the corticosteroids group had symptoms for 3-34 days
before admission. They received semi-elemental formu-
lae for 1-20 day(s) prior to admission to the UNC Hospi-
tal and then amino-acid-based formula for further 2-41
days after admission, when corticosteroids were started.
Therefore, the patients in the corticosteroid group received
semi-elemental formulae plus amino-acid-based formula
for 15-48 days prior to starting corticosteroids which
was 17-59 days after symptoms began.
Stool frequency and consistency became normal 2-
8 days (3.8±1.7 days, mean±SD) after corticosteroids
were initiated. Weight gain of more than 20 g per day
began 3-15 days after corticosteroids were initiated. Se-
rum albumin increased to greater than 3.5 g/dL 3-30 days
after treatment with corticosteroids. Therefore, for the
corticosteroids group, the total duration of diarrhoea, time
for weight gain, and normalization of albumin from the
initial onset of symptoms were 31±11, 32±11, and 39±14
days (mean±SD) respectively.  
In contrast, three infants were never treated with cor-
ticosteroids, and their loose stools and hypoalbuminae-
mia were normalized 92-141 days after onset of symp-
toms (Table 2). Consistent weight gain was not observed
until 55-95 days after discharge from hospital. The three
patients in the no-corticosteroids group required three 
Table 3. Histological findings in 13 infants with chro-
nic diarrhoea
Biopsy site     Normal      Mild    Moderate   Severe
Gastric 5 7 1 0
Duodenal 2 4 3 4
Colon 7 4 1 1
At least two biopsies were obtained at each site. A pa-
thologist assessed blindly the degree of inflammation.
Four infants had a complete colonoscopy, and 11 had
a flexible sigmoidoscopy
Fig. Photomicrograph of a duodenal biopsy demonstrating villus blunting and monocytic cell infiltration in the
lamina propria. There is crypt hyperplasia and focal cryptitis (haematoxylin and eosin, magnification x100)
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times longer to normalize stool pattern and gain weight
and albumin compared to the corticosteroids group.  
Parents of two patients initially refused corticosteroid
treatment. Their infants subsequently returned to hospi-
tal with further weight loss, acidosis, and severe diarrhoea
16 and 20 days after discharge. These infants responded
with cessation of diarrhoea after three and four days of
corticosteroid treatment and normalization of serum
bicarbonate within 48 hours and albumin within seven
days (Table 2).  
Once initial severe diarrhoea was stabilized, all infants
were exclusively fed amino-acid-based formula for at
The infants had histological evidence of inflammation,
but it was not consistent in site or severity. Patchy in-
testinal lesions that did not predict outcome have been
described in cases of protracted diarrhoea in infancy
(1). We confirmed this finding in our study. After treat-
ment with amino-acid formula and corticosteroids, but
not with amino-acid-based formula alone, all infants im-
proved dramatically, and none required long-term amino-
acid-based formula or semi-elemental formulae or corti-
costeroids. Ten patients presented to the referral hospital
with severe dehydration but responded quickly to intra-
venous fluids. Subsequently, they consumed adequate
volumes of semi-elemental formulae and looked well-
Table 4. Recovery time in infants with enteropathy with and without corticosteroid therapy
Patient no.
Corticosteroids-treated group (n=14)
1 21 14 2 5
2 17 8 8 3
4 11 7 41 3
5 8 6 13 3
7 2 1 14 2
9 10 10 5 2
10 10 18 12 8
12 28 20 7 3
14 14 7 10 5
15 22 14 16 5
18 34 12 10 2
19 14 6 10 2
20 14 1 14 5
21 10 7 10 4
No-corticosteroids treatment initially (n=5)
3 6 2 31-relapsed, then treated
11 32 14 42-recovered
16 5 4 32-relapsed, then treated
17 16 12 68-recovered

















least four months but none required amino-acid-based
formula or semi-elemental formulae after eight months.
None of these infants relapsed after corticosteroids were
discontinued. After eight months, all infants tolerated
normal diets without feeding amino-acid-based formula
or semi-elemental formulae. The duration of follow-up
has been 2-5 years without relapse in diarrhoea, weight
loss, or acidosis, and all children are taking a normal diet.
DISCUSSION
This paper presents a series of infants with protracted
diarrhoea, weight loss, hypoalbuminaemia, and acidosis.
hydrated but developed significant acidosis, low albumin,
and further weight loss at local hospital. Most referral
physicians treating these infants did not recognize the
severity of their illness until serum bicarbonate and albu-
min were checked. Results of a previous study showed
that clinical assessment of hydration in small infants
was difficult (2).
Management protocols have been devised by inves-
tigators in countries where diarrhoea is a major cause of
infant mortality (3,4). These protocols include oral rehy-
dration; antibiotic therapy as indicated; and administra-
tion of locally-available cereals, vegetable oil, minerals,
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animal milk, and yogurt. For those who fail to respond,
the diet is changed to cereals plus lactose-free carbohy-
drates (4). In developed countries, algorithms have not
been developed, but many administer protein hydrolysate
formulae that are less allergenic than cow-milk-based
formulae, often by continuous feeding, which reduces
diarrhoea and improves absorption (5). In severe cases,
infants are administered amino acid-based formula with
or without parenteral nutrition (6).
Although chronic diarrhoea in developed countries
may be perceived as a self-limiting illness, this series
demonstrates that the illness can be very severe, result-
ing in acidosis (100%), weight loss (100%), and severe
dehydration (48%). The major finding of this study is
that 14 infants (corticoisteroids group) with severe diar-
rhoea for 17-59 days dramatically improved within 
2-8 days of treatment with corticosteroids. The three in-
fants who never received corticosteroids eventually re-
covered with a total duration of symptoms three times
longer than the corticosteroids group.
The differential diagnosis includes formula protein
allergy. However, none had peripheral blood eosinophilia,
and only one patient had eosinophilic infiltration that
was found in the colon. None had other manifestations
of allergy, such as eczema or wheezing. In this study,
eight infants were tested for allergy to cow-milk and soy-
proteins using RAST IgE, and all had negative results.
All patients received semi-elemental formulae for 1-20
day(s) before admission to the UNC Hospital but did not
benefit, with persistence of diarrhoea, low serum albu-
min, and weight loss. Infants then received amino-acid-
based formula for another 2-41 days, still without any
improvement. All infants were being fed a normal diet
from eight months of age without any relapse. None of
these features is consistent with formula protein allergy.
Seven patients in the corticosteroids group received
parenteral nutrition, and the length of their admissions
was 24±11 days compared to the other seven patients in
the corticosteroids group whose duration of admissions
was only 13±4 days (p<0.001). This difference was not
due to allocation of more serious patients in the paren-
teral nutrition group but was due to the time at which
corticosteroids were started. In those infants with paren-
teral nutrition, corticosteroids were started 17±9 days after
admission, whereas for infants who did not receive
parenteral nutrition, corticosteroids were started 6±4
days after admission. Our original treatment protocol
for infants with diarrhoea included placement of a cen-
tral venous catheter and administration of parenteral nu-
trition, but as we became more confident with the use
of corticosteroids, this treatment was initiated earlier,
and infants improved so that parenteral nutrition was
unnecessary. We propose that the use of parenteral nutri-
tion and its complications may be avoided by early diag-
nosis by endoscopic biopsy and treatment with cortico-
steroids.
It is unlikely that what we are calling corticosteroid-
responsive enteropathy of infancy represents a true auto-
immune enteropathy because only four (27%) of 15
biopsied patients had severe intestinal villus atropy.
Furthermore, no patients relapsed when corticosteroids
were withdrawn (7). However, tests for anti-enterocyte
antibodies were not performed. It is unlikely that these
infants had such congenital diarrhoeas as tufting entero-
pathy, microvillus inclusion disease, glucose-galactose
malabsorption, or congenital disaccharidase deficiencies
because these entities do not respond to corticosteroid
therapy and are not self-limiting.  
During a three-year study, Catassi and colleagues re-
ported 32 cases of protracted diarrhoea, of which seven
patients died (8). Age of onset was less than three months
in 19 cases. Their study included patients with auto-
immune enteropathy (n=8), ultrastructural abnormalities
of the enterocyte (n=7), multiple food intolerances (n=3),
post-enteritis syndrome (n=2), and others.  Nine children
recovered, but their course of treatment and diagnoses
were not described. Twelve patients were given cortico-
steroids, but the effect of this treatment was not discussed.
Some cases in their population may have had a syndrome
similar to those described in this study. Furthermore,
our patients may have had Type 1 intractable diarrhoea
as described by Goulet and co-workers (9). Their pa-
tients had villus atrophy, inflammation of lamina pro-
pria and intestinal auto-antibodies. They were not syn-
dromic, as were most patients in Type II that included
tufting enteropathy. Fifty-five percent of patients des-
cribed by Goulet and co-workers died (9). Corticosteroids
were used in their patients without success.
All patients in the present study had stool cultures,
tests for ova and parasites, C. difficile toxin assay, and
rotavirus EIA studies which demonstrated no active in-
fection at the time of admission. Of the 18 infants tested
for these stool pathogens at referral hospital, only one
had a positive rotavirus EIA. This condition could repre-
sent a form of post-infectious enteropathy (10) because
either stool studies were inadequate or were poorly timed.
Our patients may fit the description of Avery and
colleagues of "chronic protracted diarrhea of infancy"
(11). This non-specific term may represent a variety of
different conditions. Ours is the first report showing the
beneficial use of corticosteroids in protracted diarrhoea
in infancy.
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A major limitation to the study is that it is retrospective
with no prospectively-designated control group. The no-
corticosteroids group served as an age-matched control
group that demonstrated eventual resolution of symptoms
over 88-141 days in the absence of corticosteroids (n=3).
In addition, two patients who did not receive cortico-
steroids initially later returned to hospital because of
worsening diarrhoea and weight loss. They subsequently
responded dramatically to corticosteroids within 4-6 days.
There are several reasons why corticosteroids may
have been beneficial for these infants. Corticosteroids
have powerful effects on intestinal absorption and diges-
tive enzymes that could be beneficial for patients with
enterocolitis. Na+ transport in the colon and small intes-
tine is stimulated, secondary to increases in mucosal
Na,K-ATPase activity, increases in colonic apical Na+
channels, and reduced inflammation (12). In neonates,
corticosteroids stimulate rapid developmental changes
in mucosal disaccharidase activities (13) and absorption
of glucose-coupled Na+ (14). Even in rotavirus-infected
piglets, treatment with corticosteroids did not prolong
illness or viral excretion; instead, treatment with cortico-
steroids promoted early regeneration of the absorptive
surface and absorption of glucose-coupled Na+ (15). In
addition, corticosteroids generally decrease inflammation
and inhibit cytokine release from inflammatory cells.
A key lesson from these cases is that it is important
to monitor serum bicarbonate and albumin in infants with
diarrhoea and poor weight gain, even if they look 'clini-
cally well'. We recommend the following plan for in-
fants aged less than three months, who present with pro-
tracted diarrhoea and with either low albumin or low bi-
carbonate. These infants should be referred to a tertiary-
care centre with paediatric gastroenterological services.
Continuous nasogastric feeds with amino-acid-based
formula should be started, and a thorough search for in-
fectious agents performed. Early endoscopic biopsies
should be obtained and, if inflammation is present in
either the stomach, duodenum, or colon, a trial of corti-
costeroids should be implemented. All the infants in
this study responded to corticosteroids within eight days.
If an infant has not responded within eight days, we re-
commend that corticosteroids be weaned. If there is a
significant response, treatment with 2 mg/kg per day
should be continued for 4-8 weeks, followed by slow
weaning.
Our results suggest that treatment with amino-acid-
based formula and corticosteroids hastens the resolution
of prolonged neonatal enteropathy with acidosis, reducing
the need for parenteral nutrition. However, close obser-
vation and supportive care may also result in resolution 
of this condition over an extended time. A double-blind
prospective study is warranted to confirm these findings.
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